These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 1323820

  • 1. Multiple mechanisms of regulation of the human c-myb gene during myelomonocytic differentiation.
    Boise LH, Gorse KM, Westin EH.
    Oncogene; 1992 Sep; 7(9):1817-25. PubMed ID: 1323820
    [Abstract] [Full Text] [Related]

  • 2. Regulation of cell proliferation: late down-regulation of c-myb preceding myelo-monocytic cell differentiation.
    Yen A, Samuel V, Forbes M.
    J Cell Physiol; 1992 Oct; 153(1):147-56. PubMed ID: 1522128
    [Abstract] [Full Text] [Related]

  • 3. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M, Boss GR, Pascual FE, Pilz RB.
    Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
    [Abstract] [Full Text] [Related]

  • 4. Relationship of acivicin-induced monocytoid differentiation of human myeloid leukemia cells to acivicin-induced modulation of growth factor, cytokine, and protooncogene mRNA expression.
    Weinberg JB, Mason SN.
    Cancer Res; 1991 Feb 15; 51(4):1202-9. PubMed ID: 1997162
    [Abstract] [Full Text] [Related]

  • 5. Absence of phorbol ester-induced down-regulation of myc protein in the phorbol ester-tolerant mutant of HL-60 promyelocytes.
    Gailani D, Cadwell FJ, O'Donnell PS, Hromas RA, Macfarlane DE.
    Cancer Res; 1989 Oct 01; 49(19):5329-33. PubMed ID: 2670202
    [Abstract] [Full Text] [Related]

  • 6. The expression and regulation of c-myb transcription in B6/lpr Lyt-2-, L3T4-T lymphocytes.
    Yokota S, Yuan D, Katagiri T, Eisenberg RA, Cohen PL, Ting JP.
    J Immunol; 1987 Oct 15; 139(8):2810-7. PubMed ID: 3116095
    [Abstract] [Full Text] [Related]

  • 7. Two transient increases in c-myc gene expression during neuroectodermal differentiation of mouse embryonal carcinoma cells.
    St-Arnaud R, Nepveu A, Marcu KB, McBurney MW.
    Oncogene; 1988 Nov 15; 3(5):553-9. PubMed ID: 3078960
    [Abstract] [Full Text] [Related]

  • 8. Microsatellite deletions in the c-myb transcriptional attenuator region associated with over-expression in colon tumour cell lines.
    Thompson MA, Flegg R, Westin EH, Ramsay RG.
    Oncogene; 1997 Apr 10; 14(14):1715-23. PubMed ID: 9135073
    [Abstract] [Full Text] [Related]

  • 9. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
    Gudas JM, Klein RC, Oka M, Cowan KH.
    Clin Cancer Res; 1995 Feb 10; 1(2):235-43. PubMed ID: 9815978
    [Abstract] [Full Text] [Related]

  • 10. Monocytic differentiation of HL-60 promyelocytic leukemia cells correlates with the induction of Bcl-xL.
    Chatterjee D, Han Z, Mendoza J, Goodglick L, Hendrickson EA, Pantazis P, Wyche JH.
    Cell Growth Differ; 1997 Oct 10; 8(10):1083-9. PubMed ID: 9342186
    [Abstract] [Full Text] [Related]

  • 11. DMSO induced modulation of c-myc steady-state RNA levels in a variety of different cell lines.
    Darling D, Tavassoli M, Linskens MH, Farzaneh F.
    Oncogene; 1989 Feb 10; 4(2):175-9. PubMed ID: 2648255
    [Abstract] [Full Text] [Related]

  • 12. Phorbol ester-mediated inhibition of growth and regulation of proto-oncogene expression in the human T cell leukemia line JURKAT.
    Makover D, Cuddy M, Yum S, Bradley K, Alpers J, Sukhatme V, Reed JC.
    Oncogene; 1991 Mar 10; 6(3):455-60. PubMed ID: 2011401
    [Abstract] [Full Text] [Related]

  • 13. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
    Gogusev J, Barbey S, Nezelof C.
    Anticancer Res; 1993 Mar 10; 13(4):1043-7. PubMed ID: 8352523
    [Abstract] [Full Text] [Related]

  • 14. Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc.
    Larsson LG, Pettersson M, Oberg F, Nilsson K, Lüscher B.
    Oncogene; 1994 Apr 10; 9(4):1247-52. PubMed ID: 8134128
    [Abstract] [Full Text] [Related]

  • 15. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
    Schmidt M, Koller R, Haviernik P, Bies J, Maciag K, Wolff L.
    Oncogene; 2001 Sep 27; 20(43):6205-14. PubMed ID: 11593429
    [Abstract] [Full Text] [Related]

  • 16. Transcriptional activation potential of normal and tumor-associated myb isoforms does not correlate with their ability to block GCSF-induced terminal differentiation of murine myeloid precursor cells.
    Patel G, Tantravahi R, Oh IH, Reddy EP.
    Oncogene; 1996 Sep 19; 13(6):1197-208. PubMed ID: 8808694
    [Abstract] [Full Text] [Related]

  • 17. Modulation of a constitutive transcriptional block at exon-1 controls human c-myc oncogene expression.
    Re GG, Antoun GR, Zipf TF.
    Oncogene; 1990 Aug 19; 5(8):1247-50. PubMed ID: 1697411
    [Abstract] [Full Text] [Related]

  • 18. Conditional inhibition of erythroid differentiation by c-Myb/oestrogen receptor fusion proteins.
    Lyon JJ, Watson RJ.
    Differentiation; 1995 Oct 19; 59(3):171-8. PubMed ID: 7589901
    [Abstract] [Full Text] [Related]

  • 19. c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines.
    Pedrazzoli P, Bains MA, Watson R, Fisher J, Hoy TG, Jacobs A.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):6911-6. PubMed ID: 2684403
    [Abstract] [Full Text] [Related]

  • 20. Effects of tiazofurin on protooncogene expression during HL-60 cell differentiation.
    Kharbanda SM, Sherman ML, Spriggs DR, Kufe DW.
    Cancer Res; 1988 Nov 01; 48(21):5965-8. PubMed ID: 2901907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.